Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon V Tiu

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Blood|November 1, 2011
Blood consult: treating del(5q) myelodysplastic syndromesSudipto Mukherjee, Ramon V Tiu, Mikkael A Sekeres
Blood Research|December 31, 2014
Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the diseaseValeria Visconte, Ramon V Tiu, Heesun J Rogers
Leukemia & Lymphoma|October 14, 2014
ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemiaVelizar Shivarov, Ralitza Gueorguieva, Milena Ivanova, et al.
Hematology. American Society of Hematology. Education Program|December 14, 2011
Clonal evolution in aplastic anemiaManuel G Afable, Ramon V Tiu, Jaroslaw P Maciejewski
Translational Medicine @ Unisa|April 30, 2014
Molecular pathogenesis of myelodysplastic syndromesValeria Visconte, Carmine Selleri, Jaroslaw P Maciejewski, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Myelodysplastic syndromes: recent advancements in risk stratification and unmet therapeutic challengesRafael Bejar, Ramon V Tiu, Mikkael A Sekeres, et al.
British Journal of Haematology|December 14, 2011
De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 cloneCraig A Portell, Mikkael A Sekeres, Heesun J Rogers, et al.
Seminars in Thrombosis and Hemostasis|May 26, 2007
Tumor lysis syndromeRamon V Tiu, Stavros E Mountantonakis, Andrew J Dunbar, et al.
Current Hematologic Malignancy Reports|February 23, 2011
Updates in cytogenetics and molecular markers in MDSRamon V Tiu, Valeria Visconte, Fabiola Traina, et al.
Expert Review of Hematology|February 5, 2013
The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?Zaher K Otrock, Ramon V Tiu, Jaroslaw P Maciejewski, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Blood|November 1, 2011
Blood consult: treating del(5q) myelodysplastic syndromesSudipto Mukherjee, Ramon V Tiu, Mikkael A Sekeres
Blood Research|December 31, 2014
Pathogenesis of myelodysplastic syndromes: an overview of molecular and non-molecular aspects of the diseaseValeria Visconte, Ramon V Tiu, Heesun J Rogers
Leukemia & Lymphoma|October 14, 2014
ASXL1 mutations define a subgroup of patients with acute myeloid leukemia with distinct gene expression profile and poor prognosis: a meta-analysis of 3311 adult patients with acute myeloid leukemiaVelizar Shivarov, Ralitza Gueorguieva, Milena Ivanova, et al.
Hematology. American Society of Hematology. Education Program|December 14, 2011
Clonal evolution in aplastic anemiaManuel G Afable, Ramon V Tiu, Jaroslaw P Maciejewski
Translational Medicine @ Unisa|April 30, 2014
Molecular pathogenesis of myelodysplastic syndromesValeria Visconte, Carmine Selleri, Jaroslaw P Maciejewski, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Myelodysplastic syndromes: recent advancements in risk stratification and unmet therapeutic challengesRafael Bejar, Ramon V Tiu, Mikkael A Sekeres, et al.
British Journal of Haematology|December 14, 2011
De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 cloneCraig A Portell, Mikkael A Sekeres, Heesun J Rogers, et al.
Seminars in Thrombosis and Hemostasis|May 26, 2007
Tumor lysis syndromeRamon V Tiu, Stavros E Mountantonakis, Andrew J Dunbar, et al.
Current Hematologic Malignancy Reports|February 23, 2011
Updates in cytogenetics and molecular markers in MDSRamon V Tiu, Valeria Visconte, Fabiola Traina, et al.
Expert Review of Hematology|February 5, 2013
The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?Zaher K Otrock, Ramon V Tiu, Jaroslaw P Maciejewski, et al.
Pageof 9